Literature DB >> 6824394

Massive hemoptysis in cystic fibrosis.

D K Porter, M J Van Every, R F Anthracite, J W Mack.   

Abstract

Massive hemoptysis occurs in 5% to 7% of patients with cystic fibrosis. Approximately 11% of these patients will die within 48 hours of manifestation because of uncontrolled hemoptysis and asphyxiation. If conservative medical treatment fails to control hemoptysis, fiberoptic or rigid bronchoscopy is the least risky and most accurate method of localizing the source of hemoptysis. Acute control of hemoptysis can be obtained in up to 100% of patients with endobronchial Fogarty balloon tamponade and in up to 88% of patients with bronchial artery embolization. Emergency thoracotomy can be performed if the above fail, but only in patients with mild cystic fibrosis and adequate pulmonary reserve.

Entities:  

Mesh:

Year:  1983        PMID: 6824394

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN: 0003-9926


  2 in total

1.  Transverse myelitis: a reversible complication of bronchial artery embolisation in cystic fibrosis.

Authors:  K L Fraser; H Grosman; R H Hyland; D E Tullis
Journal:  Thorax       Date:  1997-01       Impact factor: 9.139

2.  Efficacy, safety and usability of bronchial artery embolization using a new anti-reflux microcatheter in the management of haemoptysis.

Authors:  Salvatore Alessio Angileri; Giovanni Maria Rodà; Antonio Arrichiello; Giulia Signorelli; Letizia Di Meglio; Martina Gurgitano; Francesco Di Bartolomeo; Anna Maria Ierardi; Aldo Paolucci; Gianpaolo Carrafiello
Journal:  Acta Biomed       Date:  2020-09-23
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.